Based on Zhang et al.’s report [2], we suggest that aloperine might suppress the activation of Akt pathway and the downstream Bcl-2 expression to modulate cellular apoptosis in human thyroid cancers. This evidence concerns the gene AKT1 and thyroid gland carcinoma.